Published on June 21st, 2019 | by Saurabh0
Mitsui To Partner With Indian Company For Distributed Solar Projects
June 21st, 2019 by Saurabh
Indian solar EPC company Mahindra Susten has received a major boost in its efforts to expand its footprint in the distributed solar market with a fresh investment from a foreign company.
Mahindra Susten subsidiary Marvel Solren has received equity investment from Japan’s Mitsui & Co.. Mahindra Susten has sold a 49% stake in Marvel Solren which is engaged in development of distributed solar power projects for commercial and industrial establishments in India.
Marvel Solren currently operates four distributed solar power projects across India with a combined installed capacity of 16 megawatts. Mitsui is expected to remain highly engaged with the joint venture in order to gain further market share in the distributed solar sector. Marvel Solren hopes to have delivered a cumulative capacity of 150 megawatts by 2023.
India has lagged behind in the growth of distributed solar power market. As of 30 April 2019 only 916 megawatts of distributed solar power capacity was operational, compared to more than 28.6 gigawatts of grid-connected solar power capacity. Projects operational at the commercial and industrial scale are much fewer.
Yet, many companies are looking to set up solar generation units at their premises in order to reduce dependence power from distribution utilities for supply, save on their energy bills and fulfill their Renewable Purchase Obligation (RPO).
Mitsui’s Infrastructure Projects Business Chief Operating Officer also indicated that the joint venture company may look to expand its footprint in other countries as well with the help of Mitsui’s ‘global network’. India, in itself, represents a huge market for companies like Marvel Solren that target corporates eager to switch to renewable energy sources. According to a recent study published by WWF India, 69% of the top 100 companies listed at the National Stock Exchange are already procuring renewable energy in some form.